Table 2.
Visit | n | Total score at visit (mean (SD)) | Change from baseline (mean (SD)) |
---|---|---|---|
Baseline* | 75 | 46.03 (24.57) | |
Week 4 | 72 | 39.78 (22.72) | −7.65 (18.30) |
Week 16 | 68 | 39.48 (22.57) | −6.98 (20.85) |
Week 16 or Last Before† | 75 | 39.83 (23.90) | −6.20 (21.43) |
Week 24 | 66 | 37.17 (24.61) | −10.99 (22.51) |
Last visit‡ | 75 | 40.63 (28.38) | −5.40 (27.8) |
Last observed value before start of test drug.
Last observed value up to Visit 8 (week 16). If a patient died before week 16, the worst value of 105 was used.
Last observed value (not including follow-up). If a patient died before week 24 or during follow-up after termination before week 24, the worst value of 105 was used.
ITT, intent to treat; SD, standard deviation.